122 related articles for article (PubMed ID: 3582437)
1. Adjuvant intravesical chemotherapy of superficial bladder cancer with monthly doxorubicin or intensive mitomycin. A comparison of two consecutive series.
Ausfeld R; Beer M; Mühlethaler JP; Bartlome F; Widmer R; Tscholl R
Eur Urol; 1987; 13(1-2):10-4. PubMed ID: 3582437
[TBL] [Abstract][Full Text] [Related]
2. Randomized clinical trial on chemoprophylaxis of recurrence in cases of superficial bladder cancer.
Niijima T; Koiso K; Akaza H
Cancer Chemother Pharmacol; 1983; 11 Suppl():S79-82. PubMed ID: 6416701
[TBL] [Abstract][Full Text] [Related]
3. [Local mitomycin-C therapy of infiltrating bladder cancer].
Erdmann WD; Harzmann R; Flüchter SH; Bichler KH
Fortschr Med; 1984 Aug; 102(29-30):767-71. PubMed ID: 6437950
[TBL] [Abstract][Full Text] [Related]
4. Is there an optimal treatment scheme for adjuvant intravesical therapy? Preliminary analysis of an EORTC protocol comparing early and delayed instillation with and without maintenance of either adriamycin or mitomycin-C in patients with superficial transitional carcinoma of the bladder.
Kurth KH; Bouffioux C; Sylvester R; de Pauw M
Prog Clin Biol Res; 1988; 269():525-37. PubMed ID: 3134663
[No Abstract] [Full Text] [Related]
5. [Long-term results of intravesical prevention of recurrence with mitomycin C and adriamycin in patients with superficial bladder cancer].
Schwaibold H; Klingenberger HJ; Huland H
Urologe A; 1994 Nov; 33(6):479-83. PubMed ID: 7817443
[TBL] [Abstract][Full Text] [Related]
6. A cocktail regimen of intravesical mitomycin-C, doxorubicin, and cisplatin (MDP) for non-muscle-invasive bladder cancer.
Chen CH; Yang HJ; Shun CT; Huang CY; Huang KH; Yu HJ; Pu YS
Urol Oncol; 2012; 30(4):421-7. PubMed ID: 20870427
[TBL] [Abstract][Full Text] [Related]
7. [Can topical chemoprevention modify the rate of recurrence and progression of superficial bladder cancer?].
Egghart G; Steegmüller O; Wenderoth U; Hautmann R
Urologe A; 1988 May; 27(3):147-51. PubMed ID: 3136576
[TBL] [Abstract][Full Text] [Related]
8. Intravesical chemotherapy for carcinoma in situ of the urinary bladder: 5 years later.
Jakse G
Eur Urol; 1984; 10(5):289-93. PubMed ID: 6440791
[TBL] [Abstract][Full Text] [Related]
9. Comparison of different schedules of cytostatic intravesical instillations in patients with superficial bladder carcinoma: final evaluation of a prospective multicenter study with 419 patients.
Huland H; Klöppel G; Feddersen I; Otto U; Brachmann W; Hubmann H; Kaufmann J; Knipper W; Lantzius-Beninga F; Huland E
J Urol; 1990 Jul; 144(1):68-71; discussion 71-2. PubMed ID: 2113590
[TBL] [Abstract][Full Text] [Related]
10. Intravesical mitomycin C for the treatment of recurrent superficial bladder tumours.
Hetherington JW; Newling DW; Robinson MR; Smith PH; Adib RS; Whelan P
Br J Urol; 1987 Mar; 59(3):239-41. PubMed ID: 3105631
[TBL] [Abstract][Full Text] [Related]
11. Instillation of mitomycin C and doxorubicin in the prevention of recurrent superficial (Ta-T1) bladder cancer.
Jauhiainen K; Alfthan O
Br J Urol; 1987 Jul; 60(1):54-9. PubMed ID: 3113524
[TBL] [Abstract][Full Text] [Related]
12. [Sequential intravesical chemotherapy with mitomycin C and adriamycin for superficial bladder tumor (preliminary report)].
Fukui I; Sekine H; Yamada T; Kihara K
Hinyokika Kiyo; 1985 Apr; 31(4):623-6. PubMed ID: 3929577
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant intravesical therapy for superficial bladder cancer.
Batts CN
Ann Pharmacother; 1992 Oct; 26(10):1270-6. PubMed ID: 1421654
[TBL] [Abstract][Full Text] [Related]
14. Long-term observation after intravesical metaphylaxis with mitomycin C in patients with superficial bladder tumors.
Maier U; Höbarth K
Urology; 1991 May; 37(5):481-2. PubMed ID: 1902606
[TBL] [Abstract][Full Text] [Related]
15. 17-year follow-up of a randomized prospective controlled trial of adjuvant intravesical doxorubicin in the treatment of superficial bladder cancer.
Cheng CW; Chan PS; Chan LW; Chan CK; Ng CF; Lai MM
Int Braz J Urol; 2005; 31(3):204-11. PubMed ID: 15992422
[TBL] [Abstract][Full Text] [Related]
16. Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer.
Gofrit ON; Shapiro A; Pode D; Sidi A; Nativ O; Leib Z; Witjes JA; van der Heijden AG; Naspro R; Colombo R
Urology; 2004 Mar; 63(3):466-71. PubMed ID: 15028439
[TBL] [Abstract][Full Text] [Related]
17. The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial.
Divrik RT; Yildirim U; Zorlu F; Ozen H
J Urol; 2006 May; 175(5):1641-4. PubMed ID: 16600720
[TBL] [Abstract][Full Text] [Related]
18. Intravesical mitomycin C instillation as a prophylactic treatment of superficial bladder tumor.
Kim HH; Lee C
J Urol; 1989 Jun; 141(6):1337-9; discussion 1339-40. PubMed ID: 2498532
[TBL] [Abstract][Full Text] [Related]
19. Doxorubicin plus mitomycin C regimen in the prophylactic treatment of superficial bladder tumors.
Ferraris V
Cancer; 1988 Sep; 62(6):1055-60. PubMed ID: 3136907
[TBL] [Abstract][Full Text] [Related]
20. Recurrences during the chemoprophylactic treatment of superficial tumors of the bladder.
Ferraris V; Repetto E; Pisano PF; Albano D
J Urol; 1986 Sep; 136(3):576-9. PubMed ID: 3735530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
